Cridanimod | m-entrepreneurship.com

Product Name :
Cridanimod

Search keywords :
Cridanimod

drugId :
null

Target Vo:
Progesterone receptor

Target Vo Short Name :
PR

Moa_Name:
Progesterone receptor modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pharmsynthez

Active Company_Name :
Polysan Scientific & Technological Pharmaceutical Company

Active Indication_Name:
Respiratory Tract Infections

In Active Indication_Name:
Endometrial Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Briquilimab Epigenetics
FOXP3 Mouse (YP6049) mAb web
Wnt5a Antibody: Wnt5a Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 42 kDa, targeting to Wnt5a. It can be used for WB,ICC/IF assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts